Warm Antibody Autoimmune Hemolytic Anemia
Immunology
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| hmpl-523 | HUTCHMED (China) Limited (HCM) |
Frequently asked questions
How many drugs are in development for Warm Antibody Autoimmune Hemolytic Anemia?
BioSniper tracks 1 drug in development for Warm Antibody Autoimmune Hemolytic Anemia across 1 company.
How many clinical trials target Warm Antibody Autoimmune Hemolytic Anemia?
There are 1 clinical trial targeting Warm Antibody Autoimmune Hemolytic Anemia tracked by BioSniper.
What is the prevalence of Warm Antibody Autoimmune Hemolytic Anemia?
The estimated prevalence of Warm Antibody Autoimmune Hemolytic Anemia is approximately 5.0 per 100,000 population.
Deep-dive into Warm Antibody Autoimmune Hemolytic Anemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis